Ibnsina Pharma 2025 SR
The report for Ibnsina Pharma details the company's environmental, social, and governance disclosures for the 2024/2025 fiscal year. It highlights the company's commitment to sustainability through ISO 14001 and ISO 45001 certifications and its alignment with several UN Sustainable Development Goals. Key initiatives include the installation of solar panels to reduce carbon emissions and the implementation of waste recycling and water conservation policies. The company also emphasizes its focus on gender equality, non-discrimination, and occupational health and safety, reporting zero workplace fatalities.
Company: Ibnsina Pharma
Sector: Health Care
Country: Egypt
Year: 2025
Type: SR
Pages: 13
Ibnsina Pharma
ESG Report
The report for Ibnsina Pharma details the company's environmental, social, and governance disclosures for the 2024/2025 fiscal year. It highlights the company's commitment to sustainability through ISO 14001 and ISO 45001 certifications and its alignment with several UN Sustainable Development Goals. Key initiatives include the installation of solar panels to reduce carbon emissions and the implementation of waste recycling and water conservation policies. The company also emphasizes its focus on gender equality, non-discrimination, and occupational health and safety, reporting zero workplace fatalities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
2024 - 2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Workplace Fatalities